Parkinson’s disease is a long-term brain disorder that slowly affects how people move and control their bodies. It is one of the most common neurological conditions in the world, affecting millions of people, especially older adults.
The disease develops when certain nerve cells in the brain begin to die or stop working properly. These cells normally produce a chemical called dopamine, which helps control movement and coordination. When dopamine levels drop, the brain has difficulty sending clear signals to the muscles.
As a result, people with Parkinson’s disease may develop symptoms such as shaking of the hands, muscle stiffness, slow movement, and problems with balance. Over time, these symptoms often become more serious and can make daily activities like walking, writing, or even speaking more difficult.
Although Parkinson’s disease has been studied for many years, scientists still do not fully understand what causes it. Researchers believe the disease may develop because of a combination of genetic factors, aging, environmental exposures, and possibly certain medications.
Because of this, scientists around the world continue to study possible risk factors that might increase a person’s chance of developing Parkinson’s disease. One group of medicines that has recently drawn attention is antiepileptic drugs.
These medicines are widely used to treat epilepsy, a condition that causes repeated seizures due to abnormal electrical activity in the brain. Antiepileptic drugs help calm this activity and prevent seizures from happening. They are also sometimes prescribed for other conditions, including nerve pain, bipolar disorder, and migraine headaches.
For many patients, these medications are very important because they help control seizures and protect the brain from injury during seizure episodes. A recent study led by researchers from Queen Mary University of London explored whether these drugs might also be connected to the risk of developing Parkinson’s disease.
The research was published in the medical journal JAMA Neurology. The scientists wanted to understand whether people who used antiepileptic drugs might have a higher chance of later developing Parkinson’s disease compared with people who had not used these medicines.
To investigate this question, the researchers examined medical records from a large group of people in the United Kingdom. They compared 1,433 individuals who had been diagnosed with Parkinson’s disease with another group of 8,598 people who did not have the disease.
This second group served as a comparison group, often called a control group in medical research. The researchers then reviewed prescription records to see whether the participants had taken certain antiepileptic drugs before the diagnosis of Parkinson’s disease.
The drugs included carbamazepine, lamotrigine, levetiracetam, and sodium valproate, which are commonly prescribed medications used to control seizures. After analyzing the data, the scientists found a pattern suggesting that people who had taken these antiepileptic drugs were more likely to develop Parkinson’s disease than those who had not used them.
The connection appeared to be stronger in people who had taken higher doses of the medications or who had used several different antiepileptic drugs over time. This pattern is known as a dose-response relationship. It means that the risk appeared to increase as the exposure to the drugs increased.
In other words, people who used more of these medications or used them more often seemed to have a higher chance of developing Parkinson’s disease. The researchers noted that this does not prove the drugs directly cause Parkinson’s disease. There may be other factors involved that the study could not fully measure.
For example, the medical conditions that require antiepileptic drugs might themselves be related to neurological changes in the brain. However, the findings are still important because this is one of the first studies to examine several different antiepileptic drugs together and explore their possible relationship with Parkinson’s disease.
The study highlights the need for more research to better understand this possible connection. If future studies confirm the link, scientists will want to learn why these medicines might influence the risk of Parkinson’s disease.
Understanding the biological mechanisms behind this relationship could help researchers gain new insights into how Parkinson’s disease develops in the brain. It might even help identify new strategies for prevention or treatment. At the same time, the researchers emphasize that people should not stop taking their medications without medical advice.
Antiepileptic drugs are essential for many patients because they help prevent seizures, which can be dangerous and even life-threatening. For people with epilepsy and other seizure disorders, these medications often allow them to live safer and more stable lives.
Doctors must carefully balance the benefits and possible risks when prescribing any medication, especially drugs that people may take for many years. Studies like this help doctors better understand the long-term effects of treatments so they can make more informed decisions together with their patients.
As research continues, scientists hope to provide clearer guidance for clinicians and patients about the safest ways to manage seizure disorders while protecting long-term brain health. Future studies will likely involve larger groups of patients and may explore how different doses, treatment durations, or combinations of medications affect the risk of Parkinson’s disease.
These efforts are part of a broader scientific goal to understand Parkinson’s disease more completely and to develop better ways to prevent or treat it in the future.
If you care about Parkinson’s disease, please read studies that Vitamin B may slow down cognitive decline, and Mediterranean diet could help lower risk of Parkinson’s.
For more information about brain health, please see recent studies that blueberry supplements may prevent cognitive decline, and results showing Plant-based diets could protect cognitive health from air pollution.
Copyright © 2026 Knowridge Science Report. All rights reserved.
